Is Alexion Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Alexion Pharmaceuticals 10 years ago, but if you had invested on Tuesday 1st of February 2022 when the price was €153.90, you would have made a loss of €0.000 per share or 0.00%
No, the average daily trading liquidity for Alexion Pharmaceuticals is €70 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Alexion Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.17, the company's ability to pay off the debt is good. Alexion Pharmaceuticals has a good net profit margin of 9.94% and should have high tolerances against inflation.
We have calculated the inflation risk for Alexion Pharmaceuticals to be low [0.25 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.